blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1372645

EP1372645 - RECONSTITUTABLE PARENTERAL COMPOSITION CONTAINING A COX-2 INHIBITOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.09.2006
Database last updated on 05.10.2024
Most recent event   Tooltip29.09.2006No opposition filed within time limitpublished on 02.11.2006  [2006/44]
Applicant(s)For all designated states
Pharmacia Corporation
800 North Lindbergh Boulevard, Mail Zone 04E
St. Louis, MO 63167 / US
[N/P]
Former [2004/01]For all designated states
Pharmacia Corporation
800 North Lindbergh Boulevard, Mail Zone 04E
St. Louis, MO 63167 / US
Inventor(s)01 / KARARLI, Tugrul, T.
1700 Bluestem Lane
Glenview, IL 60025 / US
02 / NEMA, Sandeep
1526 Oxford Circle
Grayslake, IL 60030 / US
03 / KARIM, Aziz
5225 Greenleaf
Skokie, IL 60077 / US
 [2004/01]
Representative(s)Albrecht, Thomas
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[N/P]
Former [2004/01]Albrecht, Thomas, Dr.
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Application number, filing date02725471.302.04.2002
[2004/01]
WO2002US10252
Priority number, dateUS20010281058P03.04.2001         Original published format: US 281058 P
[2004/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02080912
Date:17.10.2002
Language:EN
[2002/42]
Type: A1 Application with search report 
No.:EP1372645
Date:02.01.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 17.10.2002 takes the place of the publication of the European patent application.
[2004/01]
Type: B1 Patent specification 
No.:EP1372645
Date:23.11.2005
Language:EN
[2005/47]
Search report(s)International search report - published on:EP17.10.2002
ClassificationIPC:A61K31/42, A61K9/19, A61P29/00
[2004/01]
CPC:
A61K47/18 (EP,CN,US); A61K9/08 (CN,KR); A61K9/19 (EP,CN,US);
A61K31/00 (EP,US); A61K31/122 (EP,CN,US); A61K31/365 (EP,CN,US);
A61K31/415 (EP,CN,US); A61K31/42 (EP,CN,US); A61K31/444 (EP,CN,US);
A61K31/50 (EP,CN,US); A61K45/00 (CN); A61K47/02 (EP,CN,US);
A61K9/00 (KR); A61K9/0019 (EP,CN,US); A61P29/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/01]
Extension statesAL30.09.2003
LT30.09.2003
LV30.09.2003
MK30.09.2003
RO30.09.2003
SI30.09.2003
TitleGerman:AUFLÖSBARES PULVER EINES COX-2 INHIBITORS ZUR PARENTERALEN ANWENDUNG[2004/01]
English:RECONSTITUTABLE PARENTERAL COMPOSITION CONTAINING A COX-2 INHIBITOR[2004/01]
French:COMPOSITION PARENTERALE CONTENANT UN INHIBITEUR DE COX-2 POUVANT ETRE RECONSTITUEE[2004/01]
Entry into regional phase30.09.2003National basic fee paid 
30.09.2003Designation fee(s) paid 
30.09.2003Examination fee paid 
Examination procedure28.10.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.09.2003Examination requested  [2004/01]
23.12.2003Amendment by applicant (claims and/or description)
24.05.2005Communication of intention to grant the patent
21.09.2005Fee for grant paid
21.09.2005Fee for publishing/printing paid
Opposition(s)24.08.2006No opposition filed within time limit [2006/44]
Fees paidRenewal fee
06.04.2004Renewal fee patent year 03
04.04.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US5756546  (PIROTTE BERNARD [BE], et al) [A] 1-18 * column 1, line 37 - line 42 * * example 16 *;
 [A]WO0010993  (PACIFIC CORP [KR], et al) [A] 1-18 * page 52, line 25 - page 53, line 2 *;
 [A]  - JAIN K.K., "Evaluation of intravenous parecoxib for the relief of acute post-surgical pain", EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 9, no. 11, pages 2717 - 2723, XP001084308 [A] 1-40 * paragraph [05.1] * * paragraph [06.4] *

DOI:   http://dx.doi.org/10.1517/13543784.9.11.2717
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.